Gudrian Ricardo Lopes de Almeida

Graduated in Biomedical Science at the University of Vale do Itajaí (2014), with a master's degree in Neuroscience at the Federal University of Santa Catarina (2016). PhD in Biochemistry at the Federal of Santa Catarina (2021), with an exchange DAAD/CAPES PhD program, so-called Co-financed Short-Term Research Grant at the University Medical Center of Göttingen (2019). Working in an interdisciplinary field, integrating different areas of biology and biotechnology, i.e., Proteomics, Microbiology, Genomics, Biochemistry, Pharmacology, Neuropsychopharmacology and Molecular Toxicology. Lastly working on Parkinson's cell models with the CRISPR/Cas9 approach. . Experience in Biochemistry and Pharmacology, focusing on Neuropsicopharmacology and Molecular toxicology, acting on the following subjects: methylglyoxal, neurotransmitters, molecular toxicology, fructose, and glyoxalase.

Possui graduação em Biomedicina pela Universidade do Vale do Itajaí (2014), com mestrado em Neurociências pela Universidade Federal de Santa Catarina (2016). Doutor em Bioquímica pela Federal de Santa Catarina (2021), com intercâmbio DAAD/CAPES PhD, denominado Co-financiado Short-Term Research Grant na University Medical Center of Göttingen (2019). Atuando em um campo interdisciplinar, integrando diferentes áreas da biologia e biotecnologia, ou seja, Proteômica, Microbiologia, Genômica, Bioquímica, Farmacologia, Neuropsicofarmacologia e Toxicologia Molecular. Por fim, trabalhando em modelos de células de Parkinson com a abordagem CRISPR/Cas9. Tem experiência na área de Bioquímica e Farmacologia, com ênfase em Neuropsicoparmacologia e Toxicologia Molecular, atuando principalmente nos seguintes temas: metilglioxal, neurotransmissores, toxicologia molecular, frutose e glioxalase.